株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

日本の病院での臨床科学・免疫診断市場

Japan Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts 2017-2022: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

発行 Venture Planning Group 商品コード 258715
出版日 ページ情報 英文 520 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.01円で換算しております。

Local License: 同一事業所内

Back to Top
日本の病院での臨床科学・免疫診断市場 Japan Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts 2017-2022: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
出版日: ページ情報: 英文 520 Pages
概要

当レポートでは、日本の病院検査室での臨床化学・免疫診断関連市場について分析し、市場への様々な影響要因(経済・規制・人口・社会・技術的側面)や、研究開発の最新動向と将来展望、今後5年間の市場動向(試薬・検査機器などの販売量・販売額などの予測値)、主な分析装置の機能比較、主な製品開発機会、主要企業プロファイルなどを調査して、その結果を概略以下の構成でお届けします。

イントロダクション

世界市場と技術概要

  • 主なルーチン臨床化学検査(全30種)
  • 治療薬物モニタリング検査(TDM)(全17種)
  • 内分泌機能検査(全20種)
  • 腫瘍市場と特殊化学検査(全12種)
  • 免疫タンパク検定(全7種)
  • 薬物濫用(全12種)
  • 診断装置レビュー:大〜少量/POC検査装置の運用上の特色と機能(全22社分)
  • 主な体外診断技術とその潜在的用途
    • モノクローナル・ポリクローナル抗体
    • 免疫学的検定
    • タンデム質量分析
    • ITおよびオートメーション
    • ドライケミストリー
    • バイオセンサー

日本市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの装置・試薬の売上高および市場シェア

主要製品の開発機会

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

競合企業プロファイル

  • Abbott Laboratories
  • AdnaGen
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • Dako
  • DiaSorin
  • 栄研化学
  • 富士レビオ
  • Instrumentation Laboratory
  • 協和メデックス
  • Matritech
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • シスメックス
  • Thermo Fisher
  • 東ソー
  • 和光純薬工業
  • Wallac/PE

図表一覧

目次
Product Code: VPCC25181
This new report from VPGMarketResearch.com contains 520 pages, 64 tables, and presents a comprehensive analysis of the Japanese hospital clinical chemistry and immunodiagnostics market, including:

Table of Contents

Introduction

Worldwide Market and Technology Overview

  • A. Major Routine Chemistry Tests
    • 1. Albumin
    • 2. Alkaline Phosphatase
    • 3. ALT/SGPT
    • 4. Ammonia
    • 5. Amylase
    • 6. AST/SGOT
    • 7. Bilirubin, Total
    • 8. Blood Gases
    • 9. Blood Urea Nitrogen (BUN)
    • 10. Calcium
    • 11. Cardio CRP
    • 12. Cholesterol
    • 13. Cholinesterase
    • 14. CRP
    • 15. Creatinine
    • 16. Electrolytes
      • a. Carbon Dioxide/Bicarbonate
      • b. Chloride
      • c. Potassium
      • d. Sodium
    • 17. Ferritin
    • 18. Fructosamine
    • 19. Gamma-Glutamyl Transpeptidase (GGT)
    • 20. Glucose
    • 21. High Density Lipoprotein (HDL)
    • 22. Homocysteine
    • 23. Iron
    • 24. Lactate Dehydrogenase (LDH)
    • 25. Magnesium
    • 26. Phosphorus
    • 27. Protein
    • 28. Triglycerides
    • 29. Uric Acid
    • 30. Troponin
  • B. Therapeutic Drug Monitoring (TDM)
    • 1. Overview
    • 2. Carbamazepine
    • 3. Cyclosporin
    • 4. Digoxin
    • 5. Everolimus
    • 6. Gentamicin
    • 7. Lamotrigine/Lamictal
    • 8. Levetiracetam
    • 9. Lidocaine
    • 10. Lithium
    • 11. NAPA/Procainamide
    • 12. Phenytoin
    • 13. Quinidine
    • 14. Sirolimus
    • 15. Tacrolimus
    • 16. Theophylline
    • 17. Topirimate
    • 18. Valproic Acid
  • C. Endocrine Function Tests
    • 1. Cortisol
    • 2. Estradiol
    • 3. Follicle-Stimulating Hormone (FSH)
    • 4. Gastrin
    • 5. Growth Hormone/IGF-1
    • 6. Human Chorionic Gonadotropin (HCG)
    • 7. LH
    • 8. Progesterone
    • 9. PTH/IO PTH
    • 10. Prolactin
    • 11. T3
    • 12. T3 Free
    • 13. T3 Uptake
    • 14. T4 (Thyroxine)
    • 15. T4 Free
    • 16. TBG
    • 17. Testosterone
    • 18. Thyroglobulin Ab
    • 19. TPO Ab
    • 20. TSH
  • D. Tumor Markers And Special Chemistry Tests
    • 1. AFP
    • 2. CA 15-3
    • 3. CA 19-9
    • 4. CA 27-29
    • 5. Carcinoembrionic Antigen (CEA)
    • 6. Folate/Folic Acid
    • 7. HCG
    • 8. 25-Hydroxy Vitamin D2 and D3
    • 9. Occult Blood
    • 10. Prostate-Specific Antigen (PSA)
    • 11. Thyroglobulin
    • 12. Vitamin B-12
  • E. Immunoprotein Tests
    • 1. Complement
      • a. C3
      • b. C4
    • 2. Free Light Chains
    • 3. Immunofixation
    • 4. Immunoglobulins (IgA, IgE, IgG, IgM)
    • 5. Haptoglobin
    • 6. Prealbumin
    • 7. Protein Electrophoresis
  • F. Drugs of Abuse
    • 1. Overview
    • 2. Test Methodologies
    • 3. Amphetamines
    • 4. Barbiturates
    • 5. Benzodiazepines
    • 6. Cannabinoids/Marijuana
    • 7. Cocaine
    • 8. Lysergic Acid Diethylamide (LSD)
    • 9. Methadone
    • 10. Methaqualone
    • 11. Opiates
    • 12. Phencyclidine
    • 13. Tricyclic Antidepressants
  • G. Instrumentation Review: Operating Characteristics and Features of High-, Medium-, and Low- Volume/POC Analyzers Manufactured By:
    • Abaxis
    • Abbott
    • Alere/Inverness
    • Alfa Wassermann
    • AMS
    • Awareness Technologies
    • Beckman Coulter/Olympus
    • Binding Site
    • bioMerieux
    • Carolina Chemistries
    • DiaSorin
    • Grifols
    • Horiba
    • Medica
    • Nova Biomedical
    • Ortho-Clinical Diagnostics
    • Polymedco
    • Randox
    • Roche
    • Siemens
    • Tosoh
    • Vital Diagnostics
  • H. Major In Vitro Diagnostic Technologies And Their Potential Applications
    • 1. Monoclonal and Polyclonal Antibodies
    • 2. Immunoassays
      • a. Technological Principle
      • d. Chemiluminescence
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Electrochemical
      • d. Radioimmunoassays (RIA)
      • e. Immunoprecipitation
      • f. Affinity Chromatography
    • 3. Tandem Mass Spec
    • 4. IT and Automation
    • 5. Dry Chemistry
    • 6. Biosensors

Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott Laboratories
  • AdnaGen
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • Dako
  • DiaSorin
  • Eiken
  • Fujirebio
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

List of Tables

  • Major Companies Developing or Marketing Albumin Tests
  • Major Companies Developing or Marketing Alkaline Phosphatase Tests
  • Major Companies Developing or Marketing ALT/SGPT Tests
  • Major Companies Developing or Marketing Amylase Tests
  • Major Companies Developing or Marketing AST/SGOT Tests
  • Major Companies Developing or Marketing Bilirubin Tests
  • Major Companies Developing or Marketing Blood Gas Analyzers
  • Major Companies Developing or Marketing BUN Tests
  • Major Companies Developing or Marketing Calcium Tests
  • Major Companies Developing or Marketing Cholesterol Tests
  • Major Companies Developing or Marketing Creatinine Tests
  • Major Companies Developing or Marketing Electrolyte Tests
  • Major Companies Developing or Marketing GGT Tests
  • Major Companies Developing or Marketing Glucose Tests
  • Major Companies Developing or Marketing HDL Tests
  • Major Companies Developing or Marketing Iron Tests
  • Major Companies Developing or Marketing LDH Tests
  • Major Companies Developing or Marketing Magnesium Tests
  • Major Companies Developing or Marketing Phosphorus Tests
  • Major Companies Developing or Marketing Protein Tests
  • Major Companies Developing or Marketing Triglycerides Tests
  • Major Companies Developing or Marketing Uric Acid Tests
  • Major Companies Developing or Marketing TDM Tests
  • Major Companies Developing or Marketing Digoxin Tests
  • Major Companies Developing or Marketing Lithium Tests
  • Major Companies Developing or Marketing Phenytoin Tests
  • Major Companies Developing or Marketing Theophylline Tests
  • Major Companies Developing or Marketing Valproic Acid Tests
  • Major Companies Developing or Marketing FSH Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing LH Tests
  • Major Companies Developing or Marketing Prolactin Tests
  • Major Companies Developing or Marketing T3 Tests
  • Major Companies Developing or Marketing T4 Tests
  • Major Companies Developing or Marketing TSH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Vitamin B-12/Folate Tests
  • Major Companies Developing or Marketing CRP Tests
  • Major Companies Developing or Marketing Drugs of Abuse Tests
  • Major Companies Developing or Marketing Biosensors for Clinical Chemistry Testing
  • Executive Summary Table: Japan, Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
  • Japan, Hospital Laboratories Performing Chemistry and Immunoassay Tests By Bed Size
  • Japan, Hospital Laboratories, Profiles, Panels and Individual Tests Forecast
  • Japan, Commercial/Private Laboratories, Profiles, Panels and Individual Tests Forecast
  • Japan, Hospital Laboratories, Routine Chemistry Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, Endocrine Function Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, Immunoprotein Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, TDM Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
  • Japan, Clinical Chemistry and Immunoassay Calibrator and Control Market Forecast By Test Category
  • Japan, Hospital Laboratories, Routine Chemistry Reagent Market Forecast by Assay
  • Japan, Hospital Laboratories, Endocrine Function Reagent Market Forecast by Assay
  • Japan, Hospital Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
  • Japan, Hospital Laboratories, Immunoprotein Reagent Market Forecast by Assay
  • Japan, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
  • Japan, Clinical Chemistry and Immunoassay Instrument Market Forecast By Analyzer Type
  • Japan, Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Sales and Market Shares
  • Japan, Major Suppliers of Immunoassay Products, Estimated Sales and Market Shares
Back to Top